Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women
- Cust, A.E.
- Kaaks, R.
- Friedenreich, C.
- Bonnet, F.
- Laville, M.
- Lukanova, A.
- Rinaldi, S.
- Dossus, L.
- Slimani, N.
- Lundin, E.
- Tjonneland, A.
- Olsen, A.
- Overvad, K.
- Clavel-Chapelon, F.
- Mesrine, S.
- Joulin, V.
- Linseisen, J.
- Rohrmann, S.
- Pischon, T.
- Boeing, H.
- Trichopoulos, D.
- Trichopoulou, A.
- Benetou, V.
- Palli, D.
- Berrino, F.
- Tumino, R.
- Sacerdote, C.
- Mattiello, A.
- Quiros, J.R.
- Mendez, M.A.
- Sanchez, M.J.
- Larranaga, N.
- Tormo, M.J.
- Ardanaz, E.
- Bueno-de-Mesquita, H.B.
- Peeters, P.H.
- van Gils, C.H.
- Khaw, K.T.
- Bingham, S.
- Allen, N.
- Key, T.
- Jenab, M.
- Riboli, E.
DOIAbstract
Adiponectin, an adipocytokine secreted by adipose tissue, is decreased in obesity, insulin resistance, type 2 diabetes, and polycystic ovary syndrome, all of which are well-established risk factors for endometrial cancer
Add to ORKG